Wave Life Sciences deregisters ordinary shares under Exchange Act reporting rules
WVE•Deregistration filing ends U.S. reporting status
Wave Life Sciences filed to deregister its Ordinary Shares, ending its U.S. reporting status.
The filing listed 1 holder of record for the Ordinary Shares as of Aug. 7, 2026.
